Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aryl Alkyne. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115557824A reveals a green palladium-catalyzed route for aryl alkynes using carboxylic acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN120271438A reveals a Pd-catalyzed method for aryl terminal alkyne. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed route enables high-yield aryl terminal alkyne production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101687796A details a robust Pd-catalyzed method for synthesizing heteroaryl alkynes using stable tosylates, offering significant cost and supply chain advantages for pharmaceutical intermediates.
Patent CN108276406B reveals a metal-free route to polycyclic 2-hydropyrazoles. Achieve high purity and cost efficiency in pharmaceutical intermediate manufacturing without transition metals.
Advanced mid-infrared liquid crystal compounds with high transmittance. Efficient synthesis reduces costs for display and optoelectronic material manufacturing supply chains.
Patent CN110386854A reveals a metal-free photoredox method for aryl alkynes. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN111606785B details a green, Pd-free method for aryl internal alkynes using copper catalysis and visible light, offering significant cost and supply chain advantages.
Novel one-pot synthesis method eliminates transition metals. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108484499B reveals a green rhodium-catalyzed route for isoquinoline synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108484499B reveals a green rhodium-catalyzed route to isoquinolines using hydroxylamine and alkynes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110590621B details a mild copper-catalyzed route for 1,2-bis(arylsulfonyl) ethylene derivatives, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN115677442B enables high-yield photocatalytic synthesis of alkyl aryl alkynes exceeding 42% yield through stable redox active esters, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.